mercoledì 5 settembre 2007

Linee guida sull'asma

Questo è il link alle nuove linee guida sull'asma pubblicate dal National Heart, Lung, and Blood Institute.
Almeno due elementi da citare tra gli altri:
1-particolare importanza viene data alla gestione del paziente di età compresa tra i 5 e 11 anni sembra rispodere in modo differente ai farmaci rispetto all'adulto;
2-Sottolineata l' attenzione da porre alla gestione di comorbidità come l'obesità e il reflusso gastroesofageo.

Updated guidelines on asthma diagnosis and management are available from the National Heart, Lung, and Blood Institute.

Highlights include:

-- After making the initial diagnosis and starting treatment, physicians should focus on patients' functional impairment and long-term risks.
-- Reducing the patient's exposure to indoor allergens can improve control, as can attention to other chronic problems such as gastroesophageal reflux and obesity.
-- A new age category, 5 to 11, has been added because of evidence suggesting these patients respond to drugs differently from adults.
-- For patients aged 12 or over with asthma that's inadequately controlled by low-dose inhaled corticosteroids, clinicians should consider equally either increasing the corticosteroid dose or adding long-acting beta agonists.

To more easily negotiate the 500-page document, readers should look for the boxes marked "Key Differences from 1997 and 2002 Expert Panel Reports."

1 commento:

Anonimo ha detto...

La ringrazio per Blog intiresny